首页> 美国卫生研究院文献>Frontiers in Surgery >Contemporary Management of Benign and Malignant Parotid Tumors
【2h】

Contemporary Management of Benign and Malignant Parotid Tumors

机译:腮腺良恶性肿瘤的当代管理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To report the standard of care, interesting new findings and controversies about the treatment of parotid tumors.Relevant and actual studies were searched in PubMed and reviewed for diagnostics, treatment and outcome of both benign and malignant tumors.Prospective trials are lacking due to rarity of the disease and high variety of tumor subtypes.The establishment of reliable non-invasive diagnostics tools for the differentiation between benign and malignant tumors is desirable. Prospective studies clarifying the association between different surgical techniques for benign parotid tumors and morbidity are needed. The role of adjuvant or definitive radiotherapy in securing loco-regional control and improving survival in malignant disease is established. Prospective clinical trials addressing the role of chemotherapy/molecular targeted therapy for parotid cancer are needed. An international consensus on the classification of parotid surgery techniques would facilitate the comparison of different trials. Such efforts should lead into a clinical guideline.
机译:为了报告护理标准,有关腮腺肿瘤治疗的有趣新发现和争议。在PubMed中搜索了相关和实际研究,并对良性和恶性肿瘤的诊断,治疗和结局进行了审查。需要建立可靠的非侵入性诊断工具以区分良性和恶性肿瘤。需要进行前瞻性研究,以阐明腮腺良性肿瘤不同手术技术与发病率之间的关系。建立了辅助或确定性放疗在确保局部区域控制和改善恶性疾病生存中的作用。需要针对化疗/分子靶向治疗腮腺癌的作用的前瞻性临床试验。腮腺手术技术分类的国际共识将有助于比较不同的试验。这种努力应导致成为临床指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号